Alnylam Pharmaceuticals(ALNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALNY Alnylam Pharmaceuticals

Closed Good Friday 04-02 16:00:00 EDT

318.85

-9.88

-3.01%

盘后318.85

+0.000.00%

18:32 EDT

High325.49	Low315.90	Vol872.49K
Open323.03	D1 Closing328.73	Amplitude2.92%
Mkt Cap42.12B	Tradable Cap40.22B	Total Shares132.11M
T/O278.36M	T/O Rate0.69%	Tradable Shares126.15M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALNY","market":"US","secType":"STK","nameCN":"Alnylam Pharmaceuticals","latestPrice":318.85,"timestamp":1775160000000,"preClose":328.73,"halted":0,"volume":872486,"hourTrading":{"tag":"盘后","latestPrice":318.85,"preClose":318.85,"latestTime":"18:32 EDT","volume":14981,"amount":4776608.02,"timestamp":1775169146088,"change":0,"changeRate":0,"amplitude":0.000408},"delay":0,"changeRate":-0.030055060383901665,"floatShares":126154848,"shares":132113818,"eps":2.33,"marketStatus":"Closed Good Friday","change":-9.88,"latestTime":"04-02 16:00:00 EDT","open":323.03,"high":325.485,"low":315.895,"amount":278356153.56856,"amplitude":0.029173,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1085630400000,"exchange":"NASDAQ","adjPreClose":328.73,"preHourTrading":{"tag":"盘前","latestPrice":322.61,"preClose":328.73,"latestTime":"09:29 EDT","volume":665,"amount":215509.49595,"timestamp":1775136599999,"change":-6.12,"changeRate":-0.018617,"amplitude":0.007635},"postHourTrading":{"tag":"盘后","latestPrice":318.85,"preClose":318.85,"latestTime":"18:32 EDT","volume":14981,"amount":4776608.02,"timestamp":1775169146088,"change":0,"changeRate":0,"amplitude":0.000408},"volumeRatio":0.8415572538088912,"impliedVol":0.4766,"impliedVolPercentile":0.7649},"requestUrl":"/m/hq/s/ALNY","defaultTab":"news","newsList":[{"id":"2624356186","title":"Genmab names Margarida Duarte general manager for Europe and emerging markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2624356186","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624356186?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:07","pubTimestamp":1775020077,"startTime":"0","endTime":"0","summary":"Genmab appointed Margarida Duarte as general manager for Europe and emerging markets as it expands commercial operations in the region.Duarte will lead commercial strategy and execution across those markets, including preparation for upcoming product launches.She most recently served as executive vice president and chief commercial officer at Deciphera Pharmaceuticals, overseeing commercialization in US and Europe.Earlier roles included leadership positions at Alnylam Pharmaceuticals, Exelixis, Onyx Pharmaceuticals, and Amgen.Duarte will be based in Zug and report to Genmab Chief Commercial Officer Brad Bailey.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief on A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL2CZMzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU0058720904.USD","BK4581","LU0889565916.HKD","LU0320765992.SGD","LU1057294990.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4588","BK4533","BK4139","LU0114720955.EUR","LU0882574055.USD","ALNY","IE0002141913.USD","BK4566","LU1571399168.USD","LU2112291526.USD","LU1023059063.AUD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2089984988.USD","BK4599","IE00BJJMRZ35.SGD","LU2242652126.USD","EXEL","LU0868494617.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","LU0109394709.USD","BK4532","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1983299246.USD","BK4534","BK4585","LU0289739699.SGD","SG9999001440.SGD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623583529","title":"Piper Sandler Sticks to Their Buy Rating for Alnylam Pharma (ALNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623583529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623583529?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:00","pubTimestamp":1774954821,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Alnylam Pharma today and set a price target of $489.00. According to TipRanks, Ten...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623340625","title":"Alnylam’s zilebesiran Phase 2 safety data backs ongoing Phase 3 ZENITH hypertension trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2623340625","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623340625?lang=en_us&edition=fundamental","pubTime":"2026-03-31 01:00","pubTimestamp":1774890022,"startTime":"0","endTime":"0","summary":"Alnylam highlighted new clinical trial analyses already presented at ACC.26 supporting Amvuttra  as a first-line option in ATTR cardiomyopathy.HELIOS-B follow-up showed patients on vutrisiran reported better day-to-day functioning and quality of life versus placebo.Post hoc findings indicated vutrisiran lowered risk of progression to more advanced disease, with improved survival and cardiovascular outcomes among patients who worsened on study.Alnylam also disclosed pooled Phase 2 safety results already presented for investigational hypertension drug zilebesiran, supporting continued Phase 3 development in ZENITH, initiated in September 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alnylam Pharmaceuticals Inc. published the origi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLbY1T5M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","LU0320765992.SGD","BK4588","BK4585","LU0114720955.EUR","LU0889565916.HKD","BK4139","LU0882574055.USD","ALNY","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623125333","title":"3 Stocks That May Be Trading Up To 43.2% Below Intrinsic Value Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2623125333","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623125333?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:08","pubTimestamp":1774868906,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In such conditions, identifying stocks that may be trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets in a growing market.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/3-stocks-that-may-be-trading-up-to-432-below-intrinsic-value","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/3-stocks-that-may-be-trading-up-to-432-below-intrinsic-value","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2249611893.SGD","LU0889565916.HKD","BWB","HLNE","IE00B7SZL793.SGD","LU0114720955.EUR","BK4535","AU","LU2357125470.USD","LU2506951792.HKD","DNOW","MCB","BK4017","LU0757428866.USD","BK4129","LU1223083913.SGD","LU1223082196.USD","BK4533","IE00B66KJ199.SGD","BK4522","LU0823414551.USD","BK4109","BK4211","LU1815336091.USD","ALKT","IE0031619046.USD","CXDO","LU0143863784.USD","BK4082","LU0345780281.USD","INTA","LU0330918003.SGD","LGN","LU0498741890.SGD","BHB","ALNY","BK4195","LU0823414478.USD","BK4104","BK4023","IRTC","BK4563","BK4539","SOLS","LU0788108826.HKD","LU0882574055.USD","LU0320765992.SGD","LU0496367417.USD","BK4139","LU0075056555.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622057900","title":"Alnylam Pharmaceuticals Price Target Maintained With a $510.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2622057900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622057900?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:43","pubTimestamp":1774460580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 13:43 ET (17:43 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622807452","title":"Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622807452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622807452?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:50","pubTimestamp":1774446629,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alnylam Pharma (ALNY), Biomea Fusion (BMEA) and Maze...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-alnylam-pharma-alny-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-alnylam-pharma-alny-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","LU0882574055.USD","LU0029874061.USD","BK4585","LU0109394709.USD","LU0320765992.SGD","BK4137","BLSG","BK4112","BK4588","BK4139","LU0114720955.EUR","LU0889565916.HKD","BK4581","LABU","BMEA","LU0128526141.USD","XBI","ALNY","BK4539","BLSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622020481","title":"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Alnylam Pharma (ALNY) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020481?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:10","pubTimestamp":1774437051,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ), Alnylam Pharma (ALNY) and Ultragenyx Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-alnylam-pharma-alny-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-alnylam-pharma-alny-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002224.SGD","ALNY","XLV","LU2430703251.USD","LU0345769128.USD","LU1261432733.SGD","IE00B1BXHZ80.USD","SG9999002232.USD","IE00BJT1NW94.SGD","LU0203347892.USD","IE00BZ1G4Q59.USD","IE00BN8TJ469.HKD","IE00BKVL7J92.USD","LU0058720904.USD","IE000M9KFDE8.USD","RARE","LU1074936037.SGD","XBI","IE00B3T34201.USD","BK4559","LU1430594728.SGD","LABU","IE0002141913.USD","IE00B42XCP33.USD","LU1221951129.SGD","LU1935042991.SGD","BK4137","IE00BSNM7G36.USD","LU0345770993.USD","HCSG","LU0466842654.USD","LU2505996509.AUD","LU2505996681.GBP","LU0128526141.USD","LU1674673428.USD","LU2089984988.USD","LU0683600562.USD","LU0795875086.SGD","LU1983299246.USD","SG9999001440.SGD","LU1267930813.SGD","BK4534","BK4588","LU1221951046.USD","BK4007","LU2471134523.USD","LU2129689514.USD","LU1894683348.USD","LU0234572021.USD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622027204","title":"Alnylam Pharma (ALNY) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622027204?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:57","pubTimestamp":1774436232,"startTime":"0","endTime":"0","summary":"In a report released today, Whitney Ijem from Canaccord Genuity maintained a Buy rating on Alnylam Pharma, with a price target of $429.00. Ijem cov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4548","LU0320765992.SGD","LU0114720955.EUR","BK4585","LU0882574055.USD","LU0889565916.HKD","BK4588","ALNY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622483027","title":"Analysts Conflicted on These Healthcare Names: Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622483027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622483027?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:50","pubTimestamp":1774435808,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALN...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fractyl-health-inc-guts-absci-absi-and-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fractyl-health-inc-guts-absci-absi-and-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI","GUTS","LU0882574055.USD","BK4585","BK4121","LABU","LU0320765992.SGD","HCSG","LU0114720955.EUR","XBI","XLV","BK4588","LU0029874061.USD","BK4082","ALN","BK4139","BK4137","BK4539","LU0889565916.HKD","BK4581","ALNY","BK4548","LU0109394709.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622021120","title":"Alnylam Pharma (ALNY) Gets a Buy from William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2622021120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622021120?lang=en_us&edition=fundamental","pubTime":"2026-03-25 17:38","pubTimestamp":1774431498,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter reiterated a Buy rating on Alnylam Pharma today and set a price target of $308.05. According to TipRanks, Minter...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-gets-a-buy-from-william-blair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-gets-a-buy-from-william-blair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0114720955.EUR","LU0109394709.USD","BK4548","LU0320765992.SGD","BK4588","LU0889565916.HKD","LU0882574055.USD","BK4585","ALNY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622219570","title":"Alnylam Pharmaceuticals: Durable ATTR Growth and Amvuttra Momentum Support Buy Rating and Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2622219570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622219570?lang=en_us&edition=fundamental","pubTime":"2026-03-25 17:35","pubTimestamp":1774431343,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Tazeen Ahmad has maintained their bullish stance on ALNY stock, giving a Buy rating today. Tazeen Ahmad has give...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/alnylam-pharmaceuticals-durable-attr-growth-and-amvuttra-momentum-support-buy-rating-and-upside-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/alnylam-pharmaceuticals-durable-attr-growth-and-amvuttra-momentum-support-buy-rating-and-upside-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALNY","ATTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621061321","title":"Alnylam partners with Viz.ai on AI-enabled ATTR-CM detection and care coordination pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061321","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061321?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:35","pubTimestamp":1774352123,"startTime":"0","endTime":"0","summary":"Alnylam entered a collaboration with Viz.ai to develop an AI-enabled care pathway intended to support earlier identification and referral for patients with transthyretin-mediated amyloidosis cardiomyopathy .The planned pathway combines the FDA-cleared Us2.ai echocardiography algorithm with electronic health record connectivity and integration into clinical workflows.The collaboration includes the AWARE study, a prospective implementation study evaluating AI-enabled screening in routine workflows and its impact on diagnostic timelines and care coordination.The initiative is expected to launch at 5 pilot health systems later this year.Alnylam is also supporting an American Heart Association-led, 3-year learning collaborative involving a 10-site cohort of multidisciplinary health systems focused on ATTR-CM care pathways.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL6fvvWT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0109394709.USD","BK4139","LU0889565916.HKD","BK4588","LU0114720955.EUR","LU0320765992.SGD","ALNY","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621767702","title":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-03-23","url":"https://stock-news.laohu8.com/highlight/detail?id=2621767702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621767702?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:01","pubTimestamp":1774278077,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-03-23Nasdaq 100 .NDXTop PerformersPercent ChangeInsmed Inc INSM.OQ+6.7%Applovin Corp APP.OQ+6.2%ASML Holding NV ASML.OQ+5.8%Palantir Technologies Inc PLTR.OQ+5.2%Broadcom Inc AVGO.OQ+4.8%Bottom PerformersPercent ChangeThomson Reuters Corp TRI.OQ-3.3%Kraft Heinz Co KHC.OQ-1.3%Alnylam Pharmaceuticals Inc ALNY.OQ-1.2%Micron Technology Inc MU.OQ-0.8%Linde PLC LIN.OQ-0.6%The Nasdaq 100 .NDX gained 505.90 points, or 2.12%, to 24,404.05 and recorded no new highs and one new low. 92 stocks rose and 9 fell as advancing issues outnumbered decliners by a about a 10.2-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL8N40B1N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564222.USD","LU0640476718.USD","LU2023250843.SGD","LU1064131342.USD","BK4527","LU0198837287.USD","LU1989764748.USD","LU2211815571.USD","LU0708995401.HKD","LU2108987350.USD","LU0320765992.SGD","LU1596574779.USD","IE00BKPKM429.USD","BK4533","IE00B5TLWC47.USD","LU1861559042.SGD","LU0096362180.USD","LU0238689110.USD","LU1551013425.SGD","LU0345770993.USD","LU2764262908.HKD","LU2403377893.USD","LU0171277485.USD","INSM","LU2347655156.SGD","LU1951198990.SGD","IE00BDGV0183.EUR","LU0306806265.USD","BK4575","LU2265009873.SGD","IE00BK4W5L77.USD","LU0225771236.USD","LU0109392836.USD","LU1037948897.HKD","SGXZ99366536.SGD","LU0306807586.USD","PLTU","LU0310799852.SGD","LU0289739343.SGD","LU1721427968.SGD","LU0215105999.USD","IE0001KFT4U8.USD","GB00BDT5M118.USD","LU0061475181.USD","LU0154236417.USD","LU0079474960.USD","BK4566","LU0127658192.USD","LU1720051017.SGD","LU0792757196.USD","LU2357305700.SGD","LU0234572021.USD","LU2413666004.HKD","IE00B19Z3B42.SGD","LU1244550577.SGD","LU0345774631.USD","LU2290526834.HKD","LU2506952410.USD","LU0960981461.USD","IE00BZ9MQY76.HKD","LU2286300806.USD","PLTZ","LU0784384876.USD","LU2477742899.HKD","LU0072461881.USD","LU0868494617.USD","LU2264538146.SGD","BK4585","LU1989773731.SGD","LU0912757837.SGD","03165","LU1989772923.USD","LU1267930490.SGD","LU2063271972.USD","LU0300736062.USD","BK4023","LU1934455194.USD","LU2244417387.USD","IE00BQXX3C00.GBP","LU2413666426.HKD","LU2125154935.USD","LU0203347892.USD","LU1917777945.USD","LU0957791311.USD","LU2461242641.AUD","LU2746668461.USD","LU1037948541.HKD","LU0795875086.SGD","LU0069450319.EUR","SG9999001424.SGD","LU0321505439.SGD","LU0170899867.USD","IE0002270589.USD","PLYY","LU0124384867.USD","LU0476273544.USD","LU0353189763.USD","LU2211814178.USD","IE00B1BXHZ80.USD","LU0784383803.USD","LIN","IE00B7KXQ091.USD","LU0203201768.USD","LU2023250330.USD","LU0672654240.SGD","SG9999015952.SGD","LU0689472784.USD","AVS","LU1642822529.SGD","LU1244550221.USD","LU0057025933.USD","LU1064927863.SGD","LU2242649171.HKD","LU1104425308.USD","LU1861220033.SGD","LU2322448791.USD","BK4581","LU1868836757.USD","LU0077335932.USD","LU0724618433.USD","BK4612","BK4547","LU2592432038.USD","LU1543694498.USD","IE00BKDWB100.SGD","LU2720916845.USD","LU1674673691.USD","LU0006306889.USD","BK4608","LU2764263039.SGD","KHC","IE00BVYPNQ40.USD","LU1935043023.USD","LU2125154778.USD","SG9999002232.USD","BK4605","LU1803068979.SGD","BK4598","LU2237443465.HKD","IE00BZ1G4Q59.USD","LU2355687059.USD","LU2168564495.EUR","LU0053666078.USD","LU1548497426.USD","LU1003077747.HKD","LU0300736492.USD","LU1804176565.USD","LU1934455277.USD","LU2237957902.USD","BK4553","BK4539","LU1951200564.SGD","LU0251132253.USD","LU0225283273.USD","PLT","IE0009356076.USD","LU1035775433.USD","LU0719512351.SGD","LU1923623000.USD","LU2750360997.AUD","LU0943347566.SGD","IE0034235303.USD","IE00BVYPNV92.GBP","LU1868837136.USD","LU0210536198.USD","BK4101","LU0157215616.USD","LU2860962120.EUR","IE00BFSS7M15.SGD","IE00BN29S564.USD","LU1670627923.USD","PLTY","LU0985320562.USD","LU0266013472.USD","LU1989772840.SGD","IE00B3PB1722.GBP","IE00BJTD4V19.USD","LU1620156130.USD","LU0545039389.USD","LU0466842654.USD","LU1852331112.SGD","LU2471134796.USD","BK4548","IE00B894F039.SGD","LU2023250504.SGD","LU2237443895.HKD","LU1935042488.USD","AVGX","LU0256863902.USD","IE00BWXC8680.SGD","LU2756315318.SGD","LU1366333091.USD","IE0004445015.USD","LU2168564065.EUR","BK4588","LU1720051108.HKD","LU0162691827.USD","LU0689626769.HKD","LU2272731600.USD","IE00BLSP4452.SGD","LU2237443549.SGD","LU0011850046.USD","LU1868836591.USD","APPX","BK4543","SG9999011175.SGD","LU0321505868.SGD","LU1814569148.SGD","LU0979878070.USD","IE00BJTD4N35.SGD","LU0006061336.USD","LU0208291251.USD","IE00BLSP4239.USD","LU1620156213.USD","LU0070302665.USD","LU0345769128.USD","LU0683600562.USD","LU0444973449.USD","LU1732799900.SGD","LU1712237335.SGD","LU2279689827.SGD","LU2462157665.USD","SG9999004303.SGD","IE00B775H168.HKD","BK4212","LU0949170772.SGD","LU1861558580.USD","LU0289961442.SGD","IE000M9KFDE8.USD","BK4139","LU2322448957.HKD","LU2471134952.CNY","LU1674673428.USD","LU2361044865.SGD","LU2272731782.SGD","IE00BJJMRY28.SGD","LU0082616367.USD","LU1551013342.USD","LU2430703251.USD","BK4559","LU2756315664.SGD","LU2505996509.AUD","LU1316542783.SGD",".IXIC","LU0417517546.SGD","LU2065171402.SGD","LU2168563687.JPY","LU2360107168.USD","IE00BKVL7J92.USD","LU2041044095.USD","LU2746668974.SGD","BK4579","LU1699723380.USD","LU0889565916.HKD","IE00B3S45H60.SGD","ASMG","LU0048584097.USD","LU0787776722.HKD","LU1974910355.USD","LU1670711040.USD","LU2430703095.HKD","LU0256863811.USD","LU1571399168.USD","LU0097036916.USD","LU1242518931.SGD","LU2750360641.GBP","ALNY","IE00BJJMRX11.SGD","PLOO","LU0348723411.USD","LU2298321311.HKD","LU2083900584.USD","BK4504","LU2092937221.SGD","LU2471134523.USD","LU0069063385.USD","LU0081259029.USD","LU1868837300.USD","LU0963555726.SGD","LU1323610961.USD","LU1670710661.SGD","IE00B4JS1V06.HKD","LU0053671581.USD","LU1670711123.USD","LU0171276677.USD","LU0827878280.USD","LU1670628061.USD","LU1778281490.HKD","LU1734074674.USD","LU2065169927.USD","PTIR","SG9999002224.SGD","IE00BVYPNP33.GBP","PLTW","LU2054465674.USD","LU0726765562.USD","TRI","LU2247934214.USD","LU0795875169.SGD","LU2168564149.EUR","LU2463028550.USD","LU2360106780.USD","AVL","LU0171280430.USD","LU0234570918.USD","LU0203345920.USD","LU1721428347.USD","LU2087625088.SGD","PLTD","LU0345769631.USD","LU0106261372.USD","LU1989763005.USD","IE00BD6J9T35.USD","LU0444971666.USD","LU2065171311.SGD","LU0788108743.HKD","LU1861215975.USD","LU1629891620.HKD","LU2417539215.USD","MULL","LU2458330243.SGD","LU0109394709.USD","LU0985481810.HKD","ASMU","LU0784385840.USD","LU0472753341.HKD","LU0969580561.USD","LU0345774391.USD","SGXZ51526630.SGD","LU2420271590.USD","LU1623119135.USD","LU0203202063.USD","IE00BMPRXQ63.HKD","LU0823399737.USD","LU1242518857.USD","LU1355424745.HKD","LU0868494708.USD","IE00BK4W5M84.HKD","LU1232071149.USD","LU2360108059.USD","BK4613","BK4512","IE00BGHQF631.EUR","LU0957808578.USD","IE00B19Z9Z06.USD","IE00BYV24P56.USD","LU0211328371.USD","LU0109391861.USD","LU2361044949.HKD","BK4532","LU2106854487.HKD","LU0347712357.USD","LU2237443978.SGD","LU1992135472.HKD","LU2473716301.USD","SG9999001440.SGD","LU2236285917.USD","LU0965509283.SGD","IE00B1XK9C88.USD","LU1153585028.USD","IE00BJLML261.HKD","LU1244550494.USD","LU1989764664.SGD","PLTA","LU2487616109.SGD","BK4554","LU0769137737.USD","LU2505996681.GBP","LU2213496289.HKD","BK4147","LU1691799644.USD","LU1978683503.SGD","LU1721428933.USD","SG9999015945.SGD","LU0786609619.USD","IE00B5949003.HKD","IE0034235188.USD","LU2048586759.USD","SGXZ81514606.USD","LU0553294199.USD","BK4558","LU2237443622.USD","IE00BMPRXN33.USD","LU2931357623.SGD","LU0187121727.USD","IE00B19Z9P08.USD","LU2506952337.HKD","LU0320765646.SGD","BK4534","LU2237438978.USD","LU0080751232.USD","LU1267930813.SGD","LU0965508806.USD","LU1366192091.USD","LU0738911758.USD","LU2543165471.USD","LU0225284248.USD","LU2764263203.CNY","LU2250418816.HKD","LU0096364046.USD","LU1196525536.USD","LU1935042215.USD","LU0965509101.SGD","SGXZ23171101.USD","BK4141","IE00BMPRXR70.SGD","IE00BBT3K403.USD","LU0823434583.USD","LU2361045086.USD","LU0784385170.HKD","LU1718418525.SGD","IE00B7SZLL34.SGD","LU0211327993.USD","LU0210533765.USD","LU0506197887.SGD","LU0969580488.USD","LU1127390331.HKD","PLTG","LU1992135399.USD","IE00BVYPNW00.USD","LU2347655073.USD","LU2458330169.SGD","BK4123","LU0889566641.SGD","IE00BQXX3D17.EUR","LU0949170426.SGD","LU2272731865.HKD","SG9999015978.USD","MUD","LU2298322129.HKD","LU2463526074.USD","LU1145028129.USD","LU0889565833.HKD","LU1791806182.HKD","LU2133065610.SGD","LU2602419157.SGD","LU0820561909.HKD","LU0965509010.AUD","LU0642271901.SGD","LU0316494557.USD","LU2896262040.SGD","LU0505663152.USD","IE0005OL40V9.USD","LU0511384066.AUD","LU1988902786.USD","LU0964807845.USD","LU0882574055.USD","LU1935042991.SGD","LU1815333072.USD","LU0211331839.USD","LU0353189680.USD","IE00BN8TJ469.HKD","LU1935043536.SGD","IE00B775SV38.USD","SG9999003800.SGD","LU0820562030.AUD","LU2242650005.HKD","LU1267930730.SGD","IE00B19Z3581.USD","BK4515","LU1280957306.USD","LU0345768740.USD","LU1914381329.SGD","LU2065170008.USD","LU0114720955.EUR","LU0820561818.USD","IE00BMCWC346.EUR","LU0061474960.USD","LU2237957811.SGD","LU0320765059.SGD","LU1165135440.EUR","LU1868836914.USD","LU1934455863.HKD","LU0210528500.USD","LU2413665964.HKD","LU0345768153.USD","LU0056508442.USD","IE00BQXX3F31.USD","IE00BFSS8Q28.SGD","LU0823434740.USD","LU2471134879.HKD","LU0942090050.USD","LU0323591593.USD","LU0354030438.USD","LU1162221912.USD","LU2456880835.USD","AVGU","LU2413666699.HKD","LU0861579265.USD","IE0004445239.USD","LU0274383776.USD","LU2237443382.USD","LU0526926950.USD","LU1815336760.USD","LU0354030511.USD","NDX","LU0320765489.SGD","IE00B42XCP33.USD","IE00BGHQDM52.EUR","AVGW","BK4551","LU0124676726.USD","LU2360032135.SGD","LU0345770308.USD","LU1670710588.SGD","LU1069344957.HKD","LU1301847155.USD","LU0661504455.SGD","LU2430703178.SGD","PLTI","AVGG","LU1732800096.USD","LU2089985449.USD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621770760","title":"Arbutus Biopharma FY 2025 net loss was USD 34 million, revenue rose 128% to USD 14 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770760?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:31","pubTimestamp":1774265495,"startTime":"0","endTime":"0","summary":"Arbutus published a fourth-quarter and full-year 2025 earnings release, reporting FY revenue of USD 14.1 million and a FY net loss of USD 33.5 million, or USD 0.17 per share.FY revenue rose 128% to USD 14.1 million due to recognition of previously deferred revenue tied to the conclusion of the Qilu partnership, partly offset by lower license royalty revenue linked to a decline in Alnylam’s ONPATTRO sales.Research and development expense fell 53.26% to USD 25.2 million as the company streamlined to focus on imdusiran and AB-101, including discontinuing discovery efforts and the IM-PROVE III trial.General and administrative expense decreased 28.09% to USD 15.9 million, reflecting cost-cutting that reduced compensation-related costs and legal fees.Cash, cash equivalents and marketable securities were USD 91.5 million at year-end 2025, and management said it is evaluating a return of capital in the third quarter of 2026 after receiving its portion of a USD 950 million noncontingent settlem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL6t0wKp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014005.SGD","LU0114720955.EUR","BK4112","BK4532","MRNA","LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","BK4551","BK4588","BK4501","BK4548","MRNX","BK4139","LU0320765992.SGD","BK4568","LU0314104364.USD","BK4534","IE00BN0W2T93.GBP","LU0889565916.HKD","MRNY","ALNY","LU0882574055.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","ABUS","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","NDAQ","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU0109394709.USD","BK4533","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620180737","title":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-03-20","url":"https://stock-news.laohu8.com/highlight/detail?id=2620180737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620180737?lang=en_us&edition=fundamental","pubTime":"2026-03-20 23:01","pubTimestamp":1774018877,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-03-20Nasdaq 100 .NDXTop PerformersPercent ChangeArm Holdings PLC ARM.OQ+3.9%Alnylam Pharmaceuticals Inc ALNY.OQ+2.8%Workday Inc WDAY.OQ+1.4%Copart Inc CPRT.OQ+1.3%Diamondback Energy Inc FANG.OQ+1.2%Bottom PerformersPercent ChangeWestern Digital Corp WDC.OQ-5.0%Constellation Energy Corp CEG.OQ-3.9%ASML Holding NV ASML.OQ-3.7%Micron Technology Inc MU.OQ-3.4%CrowdStrike Holdings Inc CRWD.OQ-3.3%The Nasdaq 100 .NDX lost 254.16 points, or 1.04%, to 24,101.11 and recorded no new highs and 3 new lows. 35 stocks rose and 66 fell as declining issues outnumbered advancers by about a 1.9-to-1 ratio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N4081OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0323239441.USD","LU1621767737.EUR","IE00B19Z3581.USD","LU0203347892.USD","LU2272731600.USD","LU2250418816.HKD","LU0109392836.USD","LU1734074674.USD","LU0109394709.USD","BK4533","LU2433249047.HKD","BK4097","LU1035773651.USD","LU0251142724.SGD","LU0314104364.USD","ALNY","IE00BMPRXN33.USD","IE00B7SZLL34.SGD","LU0742534661.SGD","LU1642822529.SGD","LU2125909247.SGD","LU0081259029.USD","LU1823568750.SGD","LU2298321311.HKD","LU0476273544.USD","CPRT","BK4147","BK4609","LU0889566641.SGD","CRWL","LU2265009873.SGD","LU2089985449.USD","ARMU","MULL","LU2931357623.SGD","LU0274383776.USD","WDAY","LU1992135399.USD","LU0882574055.USD","BK4606","BK4553","LU0127658192.USD","LU2458330169.SGD","ASMU","LU2384288077.EUR","LU0823434583.USD","ASML","IE00BGHQF524.EUR","LU2106854487.HKD","LU1923622291.USD","BK4139","LU1069347547.HKD","BK4551","LU0889565833.HKD","BK4579","LU2286300806.USD","LU0048573561.USD","LU1935042991.SGD","ASMG",".IXIC","BK4543","IE00BZ9MQY76.HKD","LU0889565916.HKD","LU1621767810.EUR","GB00BDT5M118.USD","LU0056508442.USD","LU2458330243.SGD","BK4588","IE00B19Z3B42.SGD","LU2087625088.SGD","LU2125909759.SGD","LU1951200564.SGD","BK4566","LU2360108059.USD","LU0823421333.USD","LU1988902786.USD","LU2272731782.SGD","LU2357305700.SGD","LU1064131342.USD","BK4023","CEGX","LU0345774391.USD","LU1323610961.USD","MUU","IE00B19Z9P08.USD","LU0642271901.SGD","IE00B2Q91V27.USD","LU1917777945.USD","IE00BD4GTT62.SGD","BK4605","LU2517655028.SGD","LU2517655374.HKD","MUD","LU0154236417.USD","LU0251131958.USD","LU1046421795.USD","BK4554","FANG","LU1267930813.SGD","LU0444971666.USD","LU1989763005.USD","LU1803068979.SGD","LU1852331112.SGD","BK4081","BK4560","IE00B19Z9Z06.USD","LU2543165471.USD","LU0353189680.USD","WDC","IE00B894F039.SGD","LU1992135472.HKD","BK4581","BK4137","LU2092937221.SGD","BK4613","LU1691799644.USD","IE00B5949003.HKD","BK4170","IE0002270589.USD","ARM","MU","LU2360106780.USD","BK4548","LU1235294995.USD","LU2125909916.SGD","IE0004445239.USD","LU2054465674.USD","LU1951198990.SGD","LU0157215616.USD","LU2023250504.SGD","BK4532","LU1093756168.USD","LU1989773731.SGD","NDX","LU1366333091.USD","LU1923622614.USD","LU1720051017.SGD","LU1935043536.SGD","IE00BD6J9T35.USD","LU0082616367.USD","IE00B3CCJ963.GBP","CEG","LU2048586759.USD","LU0323240290.USD","ARMW","LU1974910355.USD","BK4213","LU0348723411.USD","LU0957808578.USD","IE00BMPRXR70.SGD","LU1804176565.USD","LU0444973449.USD","LU0823434740.USD","CRWD","LU1093756325.SGD","BK4141","LU1815336760.USD","03165","IE0008368304.USD","LU0114720955.EUR","LU0353189763.USD","ARMG","LU2517655291.USD","WDCX","BK4575","LU0823421416.USD","BK4527","LU1720051108.HKD","LU2063271972.USD","LU0345774631.USD","LU2125909593.SGD","LU1621768206.USD","LU2211815571.USD","LU2041044095.USD","BK4528","BK4598","LU0097036916.USD","LU1923623000.USD","IE0009356076.USD","LU0320765992.SGD","LU1621768115.EUR","IE00BMPRXQ63.HKD","LU0792757196.USD","HXC","IE00BD4GTV84.USD","LU2264538146.SGD","BK4585","LU0719512351.SGD","LU1316542783.SGD","IE00BD4GTW91.USD","LU0203345920.USD","BK4512","LU0006061336.USD","LU1548497426.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619465917","title":"Alnylam Pharmaceuticals Cut to Hold From Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2619465917","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619465917?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:04","pubTimestamp":1773666240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 16, 2026 09:04 ET (13:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","ALNY","LU0882574055.USD","BK4139","BK4588","LU0114720955.EUR","BK4548","LU0889565916.HKD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619145925","title":"U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2619145925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619145925?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:00","pubTimestamp":1773655210,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit TherapeuticsMarch 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-liste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL4N4040QY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY","CVX","MPC","VLO","BC","RCL","RVMD","PFSI","ADBE","RPAY","SMMT","APEI","ECL","MUU","AALG","KYMR","APA","AROC","RBRK","AR","TALO","XOMZ","AAL","AXPG","ABVX","INCY","COGT","ALG","INSM","AA","CDRE","FITB","XOM","BLDR","MU","KO","MUD","BRBR","CRC","SCM","MULL","XOMO","PSX","PI","S","ADBG","DSGN","XOMX","AXP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2619560914","title":"Alnylam downgraded to Hold from Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2619560914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619560914?lang=en_us&edition=fundamental","pubTime":"2026-03-16 17:25","pubTimestamp":1773653122,"startTime":"0","endTime":"0","summary":"Jefferies downgraded Alnylam (ALNY) to Hold from Buy with a price target of $330, down from $522, after assuming coverage of the name. The firm is ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-downgraded-to-hold-from-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-downgraded-to-hold-from-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4548","LU0114720955.EUR","BK4139","LU0882574055.USD","BK4588","LU0320765992.SGD","ALNY","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619143092","title":"Alnylam Pharmaceuticals Inc : Jefferies Assumes Coverage With Hold VS Buy Rating; Price Target $330 VS $522","url":"https://stock-news.laohu8.com/highlight/detail?id=2619143092","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619143092?lang=en_us&edition=fundamental","pubTime":"2026-03-16 15:46","pubTimestamp":1773647206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN40115H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU0320765992.SGD","BK4139","BK4585","BK4588","LU0882574055.USD","LU0889565916.HKD","LU0114720955.EUR","BK4548","ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618975462","title":"Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2618975462","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618975462?lang=en_us&edition=fundamental","pubTime":"2026-03-12 04:37","pubTimestamp":1773261468,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027OverviewUS cardiac gene therapy developer's Q4 net loss narrowed to $20.18 mln, compared to analysts' expectations of a loss o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL1N3ZZ1BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0109394709.USD","BK4139","TNYA","LU0889565916.HKD","BK4539","BK4588","LU0114720955.EUR","LU0320765992.SGD","ALNY","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alnylam.com","stockEarnings":[{"period":"1week","weight":-0.0284},{"period":"1month","weight":0.0006},{"period":"3month","weight":-0.2032},{"period":"6month","weight":-0.3013},{"period":"1year","weight":0.195},{"period":"ytd","weight":-0.1982}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.028609},{"month":2,"riseRate":0.454545,"avgChangeRate":0.002754},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.012836},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.020458},{"month":5,"riseRate":0.619048,"avgChangeRate":0.04124},{"month":6,"riseRate":0.636364,"avgChangeRate":0.064494},{"month":7,"riseRate":0.681818,"avgChangeRate":0.106925},{"month":8,"riseRate":0.590909,"avgChangeRate":0.037005},{"month":9,"riseRate":0.545455,"avgChangeRate":0.034409},{"month":10,"riseRate":0.409091,"avgChangeRate":-0.042013},{"month":11,"riseRate":0.727273,"avgChangeRate":0.078577},{"month":12,"riseRate":0.454545,"avgChangeRate":0.006257}],"exchange":"NASDAQ","name":"Alnylam Pharmaceuticals","nameEN":"Alnylam Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alnylam Pharmaceuticals(ALNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alnylam Pharmaceuticals(ALNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alnylam Pharmaceuticals,ALNY,Alnylam Pharmaceuticals股票,Alnylam Pharmaceuticals股票老虎,Alnylam Pharmaceuticals股票老虎国际,Alnylam Pharmaceuticals行情,Alnylam Pharmaceuticals股票行情,Alnylam Pharmaceuticals股价,Alnylam Pharmaceuticals股市,Alnylam Pharmaceuticals股票价格,Alnylam Pharmaceuticals股票交易,Alnylam Pharmaceuticals股票购买,Alnylam Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alnylam Pharmaceuticals(ALNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alnylam Pharmaceuticals(ALNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}